PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.
Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertr...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0213483 |
id |
doaj-d62d1d739ab04fb888f101b54f526784 |
---|---|
record_format |
Article |
spelling |
doaj-d62d1d739ab04fb888f101b54f5267842021-03-03T20:45:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01144e021348310.1371/journal.pone.0213483PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation.Marijn RutgersFrances BachLuciënne VonkMattie van RijenVanessa AkrumAntonette van BoxtelWouter DhertLaura CreemersRegenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertrophic differentiation of mesenchymal stromal cells (MSCs) and growth plate chondrocytes. This study aims to determine the possible anabolic and/or hypertrophic effect of PTH on human articular chondrocytes. Healthy human articular cartilage-derived chondrocytes (n = 6 donors) were cultured on type II collagen-coated transwells with/without 0.1 or 1.0 μM PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and IHH and by determining glycosaminoglycan production and DNA content. The Bern score assessed cartilage quality by histology. Regardless of the concentration and initiation of supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan content and reduced the Bern score compared with controls. Type I collagen deposition was increased, whereas PTHR1 expression and type II collagen deposition were decreased by PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH and type X collagen were not affected by PTH. In conclusion, PTH supplementation to healthy human articular chondrocytes did not affect hypertrophic differentiation, but negatively influenced cartilage quality, the tissues' extracellular matrix and cell content. Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects on articular chondrocytes.https://doi.org/10.1371/journal.pone.0213483 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marijn Rutgers Frances Bach Luciënne Vonk Mattie van Rijen Vanessa Akrum Antonette van Boxtel Wouter Dhert Laura Creemers |
spellingShingle |
Marijn Rutgers Frances Bach Luciënne Vonk Mattie van Rijen Vanessa Akrum Antonette van Boxtel Wouter Dhert Laura Creemers PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. PLoS ONE |
author_facet |
Marijn Rutgers Frances Bach Luciënne Vonk Mattie van Rijen Vanessa Akrum Antonette van Boxtel Wouter Dhert Laura Creemers |
author_sort |
Marijn Rutgers |
title |
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
title_short |
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
title_full |
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
title_fullStr |
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
title_full_unstemmed |
PTH decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
title_sort |
pth decreases in vitro human cartilage regeneration without affecting hypertrophic differentiation. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2019-01-01 |
description |
Regenerated cartilage formed after Autologous Chondrocyte Implantation may be of suboptimal quality due to postulated hypertrophic changes. Parathyroid hormone-related peptide, containing the parathyroid hormone sequence (PTHrP 1-34), enhances cartilage growth during development and inhibits hypertrophic differentiation of mesenchymal stromal cells (MSCs) and growth plate chondrocytes. This study aims to determine the possible anabolic and/or hypertrophic effect of PTH on human articular chondrocytes. Healthy human articular cartilage-derived chondrocytes (n = 6 donors) were cultured on type II collagen-coated transwells with/without 0.1 or 1.0 μM PTH from day 0, 9, or 21 until the end of culture (day 28). Extracellular matrix production, (pre)hypertrophy and PTH signaling were assessed by RT-qPCR and/or immunohistochemistry for collagen type I, II, X, RUNX2, MMP13, PTHR1 and IHH and by determining glycosaminoglycan production and DNA content. The Bern score assessed cartilage quality by histology. Regardless of the concentration and initiation of supplementation, PTH treatment significantly decreased DNA and glycosaminoglycan content and reduced the Bern score compared with controls. Type I collagen deposition was increased, whereas PTHR1 expression and type II collagen deposition were decreased by PTH supplementation. Expression of the (pre)hypertrophic markers MMP13, RUNX2, IHH and type X collagen were not affected by PTH. In conclusion, PTH supplementation to healthy human articular chondrocytes did not affect hypertrophic differentiation, but negatively influenced cartilage quality, the tissues' extracellular matrix and cell content. Although PTH may be an effective inhibitor of hypertrophic differentiation in MSC-based cartilage repair, care may be warranted in applying accessory PTH treatment due to its effects on articular chondrocytes. |
url |
https://doi.org/10.1371/journal.pone.0213483 |
work_keys_str_mv |
AT marijnrutgers pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT francesbach pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT luciennevonk pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT mattievanrijen pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT vanessaakrum pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT antonettevanboxtel pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT wouterdhert pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation AT lauracreemers pthdecreasesinvitrohumancartilageregenerationwithoutaffectinghypertrophicdifferentiation |
_version_ |
1714820827123286016 |